ALLO
Allogene Therapeutics, Inc. · Healthcare
Director Owen N. Witte sold $118K of Allogene Therapeutics, Inc.
Sold$117,600
$11.76Price
10,000Shares
−4%Stake
What ALLO did after the filing
- The stock from Thu, Jun 23 close, $12.19
- +26.8%
- S&P 500, same days
- +9.4%
Measured over 30 trading days, to the Aug 5 close.
Traded Wed, Jun 22. Filed Thu, Jun 23, 12:40 PM ET, during the session. Returns use the Jun 23 close and the Aug 5 close. Not investment advice.